AUTL - Autolus Therapeutics PLC ADR (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-03-24)
Last
 1.32		 Change
 ⇓ -0.08   (-5.71%)		 Volume
  2,374,042
Open
 1.41		 High
 1.42		 Low
 1.31
8EMA (Daily)
 1.42		 40EMA (Daily)
 1.52		 50EMA (Daily)
 1.53		 STO (Daily)
 7.407		 MACD Hist (Daily)
 -0.024
8EMA (Weekly)
 1.454		 40EMA (Weekly)
 1.68		 50EMA (Weekly)
 1.78		 STO (Weekly)
 22.056		 MACD Hist (Weekly)
 -0.018
Company Profile
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises five programs: AUTO1, AUTO1/22, AUTO3, AUTO4 and AUTO6. The company operates in two geographic regions, the United Kingdom and the United States.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com